1. Home
  2. ARMP vs MNSB Comparison

ARMP vs MNSB Comparison

Compare ARMP & MNSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

SELL

Current Price

$3.02

Market Cap

199.7M

Sector

Health Care

ML Signal

SELL

Logo MainStreet Bancshares Inc.

MNSB

MainStreet Bancshares Inc.

SELL

Current Price

$20.14

Market Cap

152.7M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
ARMP
MNSB
Founded
N/A
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
199.7M
152.7M
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
ARMP
MNSB
Price
$3.02
$20.14
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $17.50
N/A
AVG Volume (30 Days)
★ 75.7K
33.0K
Earning Date
11-12-2026
10-26-2026
Dividend Yield
N/A
★ 1.95%
EPS Growth
N/A
★ 210.00
EPS
N/A
★ 1.48
Revenue
N/A
★ $135,615,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$13.86
Revenue Growth
★ N/A
N/A
52 Week Low
$2.40
$18.80
52 Week High
$14.98
$25.87

Technical Indicators

Market Signals
Indicator
ARMP
MNSB
Relative Strength Index (RSI) 46.59 26.11
Support Level $2.77 N/A
Resistance Level $3.96 $25.32
Average True Range (ATR) 0.44 0.80
MACD -0.02 -0.06
Stochastic Oscillator 43.35 8.06

Price Performance

Historical Comparison
ARMP
MNSB

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

About MNSB MainStreet Bancshares Inc.

MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.

Share on Social Networks: